IL97578A0 - Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it - Google Patents

Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it

Info

Publication number
IL97578A0
IL97578A0 IL97578A IL9757891A IL97578A0 IL 97578 A0 IL97578 A0 IL 97578A0 IL 97578 A IL97578 A IL 97578A IL 9757891 A IL9757891 A IL 9757891A IL 97578 A0 IL97578 A0 IL 97578A0
Authority
IL
Israel
Prior art keywords
dna
production
antibodies against
coding therefor
sporozoite antigen
Prior art date
Application number
IL97578A
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of IL97578A0 publication Critical patent/IL97578A0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
    • C07K16/205—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Veterinary Medicine (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Plant Pathology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physics & Mathematics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL97578A 1990-03-23 1991-03-18 Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it IL97578A0 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH97090 1990-03-23

Publications (1)

Publication Number Publication Date
IL97578A0 true IL97578A0 (en) 1992-06-21

Family

ID=4199439

Family Applications (1)

Application Number Title Priority Date Filing Date
IL97578A IL97578A0 (en) 1990-03-23 1991-03-18 Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it

Country Status (9)

Country Link
EP (1) EP0447956A1 (en)
JP (1) JPH0686679A (en)
AU (1) AU637468B2 (en)
CA (1) CA2037151A1 (en)
IE (1) IE910966A1 (en)
IL (1) IL97578A0 (en)
NZ (1) NZ237447A (en)
PT (1) PT97117A (en)
ZA (1) ZA911950B (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3355095A (en) * 1994-09-02 1996-03-27 Meiji Milk Products Company Limited Diagnostic drug for chlamydia infection
CA2388676A1 (en) * 1999-10-13 2001-04-19 Chiron Corporation Method of obtaining cellular immune responses from proteins
RU2540871C2 (en) * 2008-02-01 2015-02-10 Альфа-О Пептидес Аг Self-assembling peptide nanoparticles effective as vaccines

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ215023A (en) * 1985-02-07 1989-07-27 Smithkline Beckman Corp Vaccine against plasmodium falciparum and antigenic peptides
GB8615068D0 (en) * 1986-06-20 1986-07-23 Wellcome Found Vaccines
WO1988005817A1 (en) * 1987-01-30 1988-08-11 Smith Kline - Rit S.A. Expression of the p. falciparum circumsporozoite protein by yeast
AU625713B2 (en) * 1988-02-19 1992-07-16 Microgenesys, Inc. Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum
FR2645877B1 (en) * 1989-04-12 1991-07-05 Pasteur Institut MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING ONE, OR SEVERAL, CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY P. FALCIPARUM AT THE SPOROZOITE STAGE AND IN THE HEPATOCYTES
AU7163091A (en) * 1989-12-12 1991-07-18 Biomedical Research Institute Novel malarial sporozoite peptide antigens

Also Published As

Publication number Publication date
EP0447956A1 (en) 1991-09-25
AU7358991A (en) 1991-10-03
IE910966A1 (en) 1991-09-25
CA2037151A1 (en) 1991-09-24
NZ237447A (en) 1993-05-26
JPH0686679A (en) 1994-03-29
PT97117A (en) 1991-11-29
AU637468B2 (en) 1993-05-27
ZA911950B (en) 1991-11-27

Similar Documents

Publication Publication Date Title
SG48314A1 (en) Improved antibodies to plasmodium falciparum
HUT66753A (en) Novel antibodies and methods for their use
EP0572529A4 (en) Aptamer specific for biomolecules and method of making.
EP0492918A3 (en) Method of forming ply member
EP0245993A3 (en) Monoclonal antibodies against c5a and des-arg74-c5a, their production and use
OA07721A (en) Malaria associated antigen and preparing process thereof.
EP0456727A4 (en) Monoclonal antibodies directed against vitronectin and fibronectin, and uses thereof
GB9114468D0 (en) Antibody production
IL97578A0 (en) Plasmodium sporozoite antigen,dna coding therefor,use of said dna for its production and antibodies against it
ZA879621B (en) Method for the determination of anti-p.falciparum sporozoite antibodies in human blood
ZA937451B (en) Human monoclonal anti-peptide antibody and dna encoding thereof
EP0485476A4 (en) Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof
NZ220797A (en) Male specific antibody against male specific antigen and its production
GB8919064D0 (en) Plasmodium merozoite rhoptries antigen
EP0582450A3 (en) Anti-oxytocin receptor antibodies and methods for their production.
EP0217877A4 (en) Highly repetitive antigens of plasmodium falciparum.
EP0520436A3 (en) Monoclonal antibody, method of production thereof and use thereof
IL83231A0 (en) Small molecular weight antigen of plasmodium falciparum,antibodies directed thereto,purification and detection of said antigen
EP0446763A3 (en) Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody
ZA945696B (en) Novel Eimeria antibodies and antigens and methods of using the same
GB8921227D0 (en) Antibodies and proteins
ZA888983B (en) Rhoptry antigen of plasmodium falciparum
GB9105532D0 (en) Antibody production
GB9102294D0 (en) Antigen of plasmodium falciparum
ZA921231B (en) A plasmodium falciparum blood-stage antigen,the preparation and use thereof